Literature DB >> 26524746

Dosing Strategies of Bone-Targeting Agents-Reply.

Susan L Greenspan1, Subashan Perera1, Neil M Resnick1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26524746      PMCID： PMC4869321          DOI： 10.1001/jamainternmed.2015.4799

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.

Authors:  Susan L Greenspan; Subashan Perera; David Nace; Kimberly S Zukowski; Mary A Ferchak; Carroll J Lee; Smita Nayak; Neil M Resnick
Journal:  J Am Geriatr Soc       Date:  2012-02-08       Impact factor: 5.562

2.  Index event bias as an explanation for the paradoxes of recurrence risk research.

Authors:  Issa J Dahabreh; David M Kent
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

3.  Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams.

Authors:  I R Reid; D M Black; R Eastell; C Bucci-Rechtweg; G Su; T F Hue; P Mesenbrink; K W Lyles; S Boonen
Journal:  J Clin Endocrinol Metab       Date:  2013-01-04       Impact factor: 5.958

4.  Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.

Authors:  Andrew Grey; Mark J Bolland; Anne Horne; Diana Wattie; Meaghan House; Greg Gamble; Ian R Reid
Journal:  Bone       Date:  2012-03-24       Impact factor: 4.398

5.  Correlations of nursing home characteristics with prescription of osteoporosis medications.

Authors:  Seema Parikh; M Alan Brookhart; Margaret Stedman; Jerry Avorn; Helen Mogun; Daniel H Solomon
Journal:  Bone       Date:  2011-02-21       Impact factor: 4.398

6.  Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture.

Authors:  C Colón-Emeric; K W Lyles; D A Levine; P House; A Schenck; J Gorospe; M Fermazin; K Oliver; J Alison; N Weisman; A Xie; J R Curtis; K Saag
Journal:  Osteoporos Int       Date:  2006-11-21       Impact factor: 4.507
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.